The global electroceutical devices market revenue is expected to register a moderate CAGR over the forecast period. Increasing number of cases of chronic diseases across the globe is expected to drive the growth of the market over the forecast period. In addition, technological advancements and increasing number of product approvals is other factor expected to drive growth of the market over the forecast period.

The global electroceutical devices market report has been segmented on the basis of product, type of device, end user, and region.

On the basis of product, the global target market is segmented based on cardiac pacemakers, implantable cardioverter defibrillators, retinal implants, cochlear implants, spinal cord stimulators, deep brain stimulators, and others.

On the basis of type of device, the global electroceutical devices market is segmented based on implantable electroceutical devices and non-invasive electroceutical devices. The implantable electroceutical devices segment accounted for major revenue share over the forecast period.

On the basis of end user, the target market is segmented based on hospitals, academic research institutions, and ambulatory surgical centers. The hospital segment accounted for major revenue share over the forecast period, owing to increasing number of surgeries performed in hospitals.

Request for the Sample Report Here: https://marketresearch.biz/report/electroceutical-devices-market/request-sample/

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major revenue share and is expected to maintain its dominance over the forecast period. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like China and India is expected to support the growth of the market in Asia Pacific, owing to the increasing the prevalence of hearing loss and increasing number of cases of the neurological disorder in these countries over the forecast period.

Some prominent players in the global electroceutical devices market are Medtronic plc, Cochlear Ltd., Sonova Holding AG, Abbott Laboratories, Advanced Bionics AG, Boston Scientific Corporation, ElectroCore, Inc., Biotronik, ReShape Lifesciences, Inc., and LivaNova, PLC.

 

Leave a Reply

Your email address will not be published. Required fields are marked *